Latest Financial Guidance News

Growthpoint Properties Australia has announced a final distribution of 9.1 cents per security for FY25, maintaining its full-year guidance and sustainability commitments.

EZZ Life Science has launched its US-focused brand EZZDAY with four FDA-registered supplements, marking a major step in its international growth strategy. The company has also begun US-based manufacturing and opened an online store to target American consumers.

HomeCo Daily Needs REIT has recorded a $142 million preliminary valuation gain for the June 2025 quarter, driven by income growth and cap rate tightening, while reaffirming its full-year distribution guidance.

Viva Leisure has launched a refreshed corporate brand and published 'The Viva Story,' outlining its transformation into a global, technology-driven fitness ecosystem.

Bioxyne Limited's subsidiary Breathe Life Sciences has achieved key GMP certifications across multiple international markets, paving the way for expanded operations in Europe, the UK, Canada, and Singapore. The company signals strong growth prospects for FY2026, with formal guidance expected in August.

Motio Limited has upgraded its FY25 revenue and EBITDA guidance following unexpectedly strong trading conditions after the Federal Election, driven by a surge in national and programmatic advertising.

Emeco Holdings has reaffirmed its FY25 guidance, targeting $300 million in operating EBITDA and signalling confidence in earnings growth for FY26 amid disciplined cost management and a resilient mining sector.

ASIC has initiated a comprehensive compliance inquiry into ASX’s governance, risk management, and operational capabilities, folding its previous CHESS incident probe into this broader review. ASX pledges full cooperation amid ongoing technology upgrades.

Saunders International announces the planned resignation of CEO Mark Benson by year-end alongside a notable downgrade in FY25 revenue and earnings guidance due to project delays and weather disruptions.

CLINUVEL Pharmaceuticals announces the full-time return of Managing Director Dr Philippe Wolgen, focusing on advancing critical product development and corporate initiatives, while Acting CEO Lachlan Hay continues until September 2025.

ASX Limited reveals steady progress on its FY28 strategy, emphasizing technology modernization and operational resilience while providing detailed financial guidance through FY27.

GenusPlus Group has landed a $130 million contract to upgrade NBN’s Fibre to the Node network across Western Australia, targeting 22,000 properties over the next 3.5 years.